The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma

Annals of Oncology

Volumn 8, Issue SUPPL. 2, 1997, Pages

  Johnson, P W M ^a   Leek, J ^a   Swinbank, K ^a   Angus, B ^b   Roberts, P ^a   Markham, A F ^a   Selby, P J ^a   MacLennan, K A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Anaplastic large cell lymphoma; Fluorescent in situ hybridization; Hodgkin's disease; Ki 1 lymphoma; PCR

Indexed keywords

CD15 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; NUCLEOPHOSMIN; POLYCLONAL ANTIBODY; PROTEIN; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME PAINTING; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOGENETICS; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030853013     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_2.S65     Document Type: Conference Paper

References (28)

1. Fischer P, Nacheva E, Mason DY et al. A Ki-1 (CD39) positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor B-chain. Blood 1988; 72: 234-40.
2. Stein H, Mason DY, Gerdes J et al. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848-58.
3. Kadin ME, Sako D, Berliner N et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 68: 1042-9.
4. Bitter MA, Franklin WA, Larson RA. Morphology in Ki-1 (CD30) positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305-16.
5. Greer JP, Kinney MC, Collins RD et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991; 9: 539-47.
6. Nakamura S, Takagi N, Kojima M et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1 positive large cell lymphoma) among the Japanese. Cancer 1991; 68: 118-29.
7. Filippa D, Ladanyi M, Wollner N et al. CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996; 87: 2905-17.
8. Chott A, Kaserer K, Augustin I et al. Ki-1 positive large cell lymphoma: A clinicopathologic study of 41 cases. Am J Surg Pathol 1990; 14: 439-48.
9. Sandlund JT, Pui C-H, Santana VM et al. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 895-8.
10. Offit K, Ladanyi M, Gangi MD et al. Ki-1 antigen expression defines a favorable clinical subset of non-B-cell non-Hodgkin's lymphoma. Leukemia 1990; 4: 625-30.
11. Reiter A, Schrappe M, Tiemann M et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 1994; 12: 899-908.
12. Romaguera J, Manning J, Tornos C et al. Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol 1994; 5: 317-22.
13. Morris SW, Kirstein MN, Valentine MB et al. Fusion of a kinase gene, Alk, to a nucleolar protein gene, Npm, in non-Hodgkin's lymphoma. Science 1994; 263: 1281-4.
14. Ladanyi M, Cavalchire G, Morris SW et al. Reverse-transcriptase polymerase chain-reaction for the ki-1 anaplastic large-cell lymphoma-associated t(2-5) translocation in Hodgkin's-disease. Am J Pathol 1994; 145: 1296-300.
15. Downing J, Shurtleff S, Head D et al. Molecular-detection of t(2-5) of non-Hodgkin's-lymphoma by reverse-transcriptase polymerase chain-reaction (rt-PCR). Blood 1995; 85: 3416-22.
16. Elmberger PG, Lozano MD, Weisenburger DD et al. Transcripts of the npm-alk lymphoid lesions. Blood 1995; 86: 3517-21.
17. Wellman A, Otsuki T, Vogelbruch M et al. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995; 86: 2321-8.
18. Lamant L, Meggetto F, Alsaati T et al. High-incidence of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma and its lack of detection in Hodgkin's disease - comparison of cytogenetic analysis, reverse transcriptase-polymerase chain-reaction, and p-80 immunostaining. Blood 1996; 87: 284-91.
19. Orscheschek K, Merz H, Hell J et al. Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23:q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 1995; 345: 87-90.
20. Bullrich F, Morris SW, Hummel M et al. Nucleophosmin (npm) gene rearrangements in ki-1 positive lymphomas, Cancer Res 1994; 54: 2873-7.
21. Yee HT, Ponzoni M, Merson A et al. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma (ki-1) and Hodgkin's disease, Blood 1996; 87: 1081-8.
22. Shiota M, Fujimoto J, Takenaga M et al. Diagnosis of t(2;5)-(p23;q35)-associated Ki-1a lymphoma with immunohistochemistry. Blood 1994; 84: 3648-52.
23. Anand R, Riley JH, Butler R et al. A 3.5 genome equivalent multi access YAC library: Construction, characterisation, screening and storage. Nucleic Acids Res 1990; 18: 1951-6.
24. Elmslie EA, Jones TA, Sheer D et al. The CL100 gene, which encodes a dual specificity (Tyr/Thr) MAP kinase phosphatase, is highly conserved and maps to human chromosome 5q34. Human Genet 1994; 93: 513-6.
25. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83: 2934-8.
26. Landegent JE, Jansen in de Wal N, Dirks RW et al. Use of whole cosmid cloned genomic DNA sequences for chromosomal localisation by non-radioactive in situ hybridization. Human Genet 1987; 77; 366-70.
27. Weiss LM, Lopategui JR, Sun LH et al. Absence of the t(2;5) in Hodgkin's disease. Blood 1995; 85: 2845-7.
28. Shiota M, Nakamura S, Ichinohasama R et al. Anaplastic large-cell lymphomas expressing the novel chimeric protein p80(npm/ alk) - a distinct clinicopathological entity. Blood 1995; 86: 1954-60.